Cell Science 2020.jpg
Date

August 28-29, 2020

Location

Holiday Inn Atrium, Singapore

--}}

Cell Science 2020 Conference Overview


After the grand success of Cancer Biology 2019, Larix International Pte Ltd is proudly announcing 3rd International Conference on Cancer Biology and Cell Science which is going to be held in the beautiful city, Singapore on August 28-29, 2020 with the theme, Enlightening latest advancements in cancer diagnosis and therapy

Cell Science 2020 provides a vibrant platform for sharing knowledge among the Oncologists, haematologists, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. The workshops are designed for academia and industrial benefits who want to have updated knowledge on management and treatment techniques. The Conference gathers expert surgeons in the world to share their experience and guide participants to explore advanced surgical techniques.

  • Best Oral Presentation Award
  • Poster Presentation Award
  • Young Research Forum
  • 3 Minutes thesis
  • Network with hundreds of attendees and see how they’re addressing challenges.
  • Experience the most respected additive conference, with over 20+ knowledgeable speakers.
  • Collaborate with users to advance applications for technologies.

IMPORTANT DATES


  • Abstract Submission opens:

    February 01, 2020


  • Abstract Submission Deadline:

    May 30, 2020


  • Standard Registration opens:

    February 18, 2020


  • Standard Registration Deadline:

    June 6, 2020

Session 1: Cancer Biology

 

Cancer systems biology encompasses the application of systems biology approaches to cancer analysis, so as to check the sickness as a complex adaptive system with rising properties at multiple biological scales. Cancer systems biology represents the application of systems biology approaches to the analysis of how the intracellular network of traditional cells are rattled during carcinogenesis to develop effective predictive models that can assist scientists and clinicians in the validations of new therapies and drugs. Tumours are characterized by genomic and epigenetic instability that alters the functions of many different molecules and networks in a single cell as well as altering the interactions with the local environment. Cancer systems supports the utilization of process and mathematical strategies to decipher the complexness in tumorigenesis additionally as cancer heterogeneousness.

Session 2: Cancer Biomarkers

                                            

Protein Biomarkers are often used as biomarkers for early detection of cancers particularly used for the identification of carcinoma.

 

Diagnostic Patients with suspected pancreatic cancer will undergo an initial CT scan to determine if a suspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-resectable stage III and IV disease and a diagnostic test are undertaken to verify carcinoma by H&E pathological analysis.

 

The presence of cancerous cells via pathology is extremely difficult because of high numbers of non-cancerous stromal infiltrating cells and administration of therapy or enrolment into a clinical test will only begin on definitive diagnosing of carcinoma.

 

These will notice specifically stains neoplastic pancreatic cells would enable the pathologist to confidently diagnose pancreatic cancer and thus offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 is known as a sensitive (98%) and specific (95%) IHC marker for carcinoma and gas-discharge tube is seeking a partner to develop an IHC primarily based test to detect BI-010 in fine needle aspirate biopsies from biopsy samples.

 

Session 3: Translational Oncology

 

Translational Oncology is the field of Cancer Research where a series of research conducted at the labs come out with a novel approach towards the cancer therapy. This branch of science involves many interdisciplinary subjects. Researchers here will have to be familiar with all the knowledge. This is considered to be the next big thing in Cancer Research with great no of employability and Commercial opportunities available. Translational research has advanced from recognizing a solitary change driving genome to the high-throughput cutting edge entire genome sequencing investigations. Late advances in Omics have expanded our insight into the procedures underlying malignancy development.

Session 4: Radiation Oncology

 

It is one of the 3 basic specialties, the opposite 2 being a surgical and therapeutic medical specialty, related to the treatment of development.

Radiation can be given as a therapeutic system, either alone or in combination with surgery or probably therapy. The mission of Advances in Radiation Oncology is to give unique clinical research went for improving the lives of people living with tumor and distinctive ailments treated with radiation treatment.  Radiation Therapy, Predictive Oncology, Cancer Imaging, Stem Cell Therapy, Oncology Nursing

 

Session 5: Cancer Diagnosis

 

Cancer is considered to be the main reason for deaths across the world.


The cure for cancer is still a matter of research. However, there are few curing techniques available only if the person is diagnosed at the early growth stages. So cancer identification becomes a really necessary part of associate individual’s survival. Since the cancer cells exhibit properties of a normal cell until it reaches malignant stages, it becomes difficult to diagnose. However few symptoms will act just like the signals for cancer growth. Once these symptoms are encountered one can endure diagnosing techniques like the diagnostic tests, Radiography etc. Through these strategies, the practician is going to be ready to predict the stage of cancer and survivability of the patients.

Session 6: Cancer Immunotherapy & Vaccines

 

Cancer therapy (Immuno-oncology or Immuno-oncology) is that the use of the system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid (active and passive). These approaches exploit the very fact that {can|which will|that may}cer cells usually have molecules on their surface that can be detected by the immune system, called tumour-associated antigens (TAAs); they're often proteins or other macromolecules (e.g. carbohydrates). Active immunotherapy directs the system to attack growth cells by targeting TAAs. Passive immunotherapies enhance existing anti-tumor responses and include the use of monoclonal antibodies, lymphocytes and cytokines.

Session 7: Cancer Biomarkers

 

Protein Biomarkers are often used as biomarkers for early detection of cancers particularly used for the identification of carcinoma. Diagnostic Patients with suspected pancreatic cancer will undergo an initial CT scan to determine if asuspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-resectable stage III and IV disease and a diagnostic test are undertaken to verify carcinoma by H&E pathological analysis. The presence of cancerous cells via pathology is extremely difficult because of high numbers of non-cancerous stromal infiltrating cells and administration of therapy or enrolment into a clinical test will only begin on definitive diagnosing of carcinoma. These will notice specifically stains neoplastic pancreatic cells would enable the pathologist to confidently diagnose pancreatic cancer and thus offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 is known as a sensitive (98%) ANd specific (95%) IHC marker for carcinomaand gas-discharge tube is seeking a partner to develop an IHC primarily based test to detect BI-010 in fine needle aspirate biopsies from biopsy samples.

Session 8: Cancer Metabolism

 

Cancer metabolism refers to the alterations in cellular metabolism pathways that are evident in cancer cells compared with most conventional tissue cells. Metabolic alterations in cancer cells are various and include aerobic glycolysis, reduced biological process and also the multiplied generation of synthesis intermediates required for cell growth and proliferation.

Session 9: Cancer Epigenomics

 

Cancer epigenetics means studying epigenetic modifications to the genome of cancer cells that do not involve a change in the nucleotide sequence. Epigenetic corrections are important like genetic alterations, the transition of a cell from normal to tumorous, and their manipulation holds great promise for cancer prevention, detection, and therapy. In different cancers, a diversity of epigenetic mechanisms can be perturbed, such as silencing of tumor suppressor genes and activation of oncogenes by altered CpG island methylation patterns, histone modifications and dysregulation of DNA binding proteins.

Session 10: Cancer genomics

 

• Epigenetic influence on genomic stability

• Molecular underpinnings of therapeutic targets

• Aberrant DNA methylation genes

• Tumor heterogeneity

Session 11: Cancer Inflammation and Immune Tolerance

 

It is widely believed that chronic inflammation critically adds to cancer. Immune tolerance in cancer intermediates tumor escape from the immune system. Inflammation mediates tumor-induced tolerance. The induction and maintenance of the chronic inflammatory response is a universal mechanism of immune tolerance.

Session 12: Nanoparticles in Cancer Therapy

 

Since the last decade nanoparticles have been of significant interest as they offer great benefits in drug delivery to overcome limitations present in the case of conventional chemotherapy. Sizes range from (1-1000 nm) and also made by using a variety of materials including polymers, lipids, inorganic materials and biological materials. Targeted particles are used which are nano range to carry chemotherapeutic agents in cancer therapy, offer many advantages to improve drug/gene delivery and to overcome many problems associated with conventional chemotherapy.

Session 13: Novel Approaches to Cancer Therapeutics

 

The standard management modalities are associated with severe side effects and high toxicity which in turn lead to low quality of life. This encompasses novel strategies for more effective chemotherapeutic delivery aiming to generate better prognosis. Cancer treatment is a dynamic field and significant advances are being made in the development of novel cancer treatment strategies. The difference to conventional cancer therapeutics, novel approaches such as ligand or receptor based targeting, intracellular drug targeting, gene delivery, cancer stem cell therapy, magnetic drug targeting and ultrasound-mediated drug delivery, have extra new modalities for cancer treatment.

Session 14: Cancer Epigenetics

 

• Molecular Profiling Techniques

• New Biologics & Vaccines

• Chemical Proteomics

• Combination Strategies in Immuno-oncology

• Novel Biomarker Discovery

Session 15: Cancer Prevention & Therapy

 

Malignancy represents the treatment of tumour in a patient, regularly with surgery, chemotherapy or potentially radiotherapy. Treatments are likewise available for some disease composes. A malignancy subject may get a wide range of treatment, including those going for mitigating the manifestations of disease, for example, torment. Chemotherapy, as a rule, alludes to the utilization of pharmaceuticals or medications to treat disease. The possibility of having chemotherapy panics numerous individuals. Be that as it may, realizing what chemotherapy is, the manner by which it works and what's in the store can frequently help quiet your feelings of trepidation. It can likewise can be superior of controlling over your disease treatments. Directed treatment is a unique sort of chemotherapy that exploits the contrast between typical cells and malignancy cells. It's infrequently applied alone, however, frequently other malignancy medications are utilized with a focused treatment.

Session 16: Chemotherapy

 

Chemotherapy (Chemo) is a sort of treatment that incorporates a pharmaceutical or blend of drugs to treat the tumor. The objective of chemo is to stop or moderate the development of growth cells. Chemo is viewed as a foundational treatment. This implies it might influence your whole body. Chemo meds assault quickly developing malignancy cells, yet they can likewise influence solid cells that develop quickly. Chemotherapy is the use of any pharmaceutical to treat any malady. Regardless, to a large number of individuals, the word chemotherapy suggests drugs used for ailment treatment. It's every now and again condensed to "chemo." Surgery and radiation treatment expel, murder, or damage illness cells in a particular area, yet chemo can work all through the whole body. This infers chemo can pulverize harm cells that have spread (metastasized) to parts of the body a long way from the principal (fundamental) tumour.

Session 17: Cancer Immunology

 

As stated earlier, cancer research is an interdisciplinary subject; Cancer Immunology is a branch of science which deals with the role of host immunity and its behavior to the growth of cancer. The immune system assists to fighting against the foreign invaders. However, cancer cells not being foreign cells to the host are very difficult to be identified by the host immunity as a threat. Only when the cancer cells start to release certain molecules which are specific to the cancer cells, host immune cells try to act against the cancer cells.

Session 18: Hematology-Oncology

 

Hematologic Oncology is the branch of medical study about the diagnosis, prevention, treatment, and avoidance of disease identified with blood. Hematology is learning about etiologists which includes treating the disease that influences the production of blood and its parts, for example, platelets, haemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the component of coagulation. Haematologists study oncology and work with oncologists, individuals who may specialize just in that field rather than both-the therapeutic treatment of the tumor. There are different disorders that people are influenced by haematology. Different type of blood conditions that are looked at incorporate anemia, hemophilia, general blood clots, bleeding disorders, and so forth. Related blood diseases, leukemia, myeloma, and lymphoma, these are more serious cases that should be analyzed.

Session 19: Organ-Specific Cancers

 

One of the leading causes of death all over the world is Cancer. Organ Cancers are cancers named based on the location of cancer in the parts of the body. There are different types of cancers, some of them are Head and Neck Cancer, Brain cancer, Lung cancer, Oral cancer, Liver cancer, Breast cancer, Prostate cancer, Gastric cancer, Pancreatic cancer, Kidney (Renal Cell) Cancer, Leukemia and many more.  Stomach, prostate, Lung, colon & rectum, and liver are commonly affected by cancer in men. In women, the most common organs affected are breast, colon, rectum, lung, cervix, and stomach.

Session 20: Cancer Stem Cell Therapy

 

Stem cell transplantation is a procedure that reinstates blood-forming cells in people who have had theirs destroyed by the very high doses of chemotherapy or radiation therapy are used to treat certain cancers. Blood stem cells are important because they grow into different types of blood cells.

 

• Stem Cells and Tumors

• Stem Cell Transplantation

• Bone Marrow Transplantation

• Cord Blood Stem Cells and Cancer

• Stem Cell Research

Session 21: Stem Cell and Pathophysiology


Multiplication of the parenchymal cells is directed by various cytokine/development factor-interceded pathways and is convenient synchronized with extracellular grid corruption and the rebuilding of the vasculature. The putative job of undifferentiated organisms in physiology, pathophysiology, and treatment isn't yet exactly known however at present is under escalated examination. The vast majority of distributed information, in any case, presently propose that they don't assume an important job in substitution of epithelial cells in any known type of hepatic damage. In vitro separation conventions for different grown-up extrahepatic undeveloped cells may in the end give important wellsprings of cells to transplantation and treatment.

 

Amniotic epithelial foundational microorganisms, fatal liver forebear cells just as embryonic undifferentiated organisms as of now rise as elective undeveloped cell sources and open new conceivable outcomes for cell treatments of liver infection.

Our Speakers


Larix Conferences 2020 - the day is designed to make it happen!.
Witness some of the great leaders, bright minds leading the industrial revolution and business innovators sharing insights on embracing the future and advancing their knowledge with scientific solutions.
Inspiring keynote presentations

Previous Conference


Testimonials


Venue & Updates


singaapore.jpg

Singapore


Singapore is an island and a country, but perhaps its best description is that of city-state. Singapore is a melting pot of culture and history, and an extravaganza of culinary delights. Singapore is... Read More
holiday inn atrium.jpg

Venue- Holiday Inn Atrium


Situated steps from the iconic Singapore River in the heart of the city, Holiday Inn Singapore Atrium provides the perfect location for business and leisure guests.A 25-minute ride from Changi Airport... Read More
images (1).jpg

Recent Updates


Cell Science 2020 provides recent updates in the field of Cancer Biology and Cell Science.  Read More

Attended by Industry Leaders


Media Partners


allconferencealert.png
logo.png
eventsnow.png
KC LOGO 2.jpg
download.png
ae-logo.png
worlds.png
Facebook
Pinterest
Twitter
LinkedIn
blog Blog
Youtube